Exclusive

Publication

Byline

Florricks Lifecare expands global footprint with $95 M investment in Europe and Hong Kong

Singapore, Feb. 27 -- Florricks Lifecare, a leading research-driven pharmaceutical company in India, involved in R&D, production, and sales of Active Pharmaceutical Ingredients (API) and Finished Dosa... Read More


Singapore's Respiree receives regulatory approval for paediatric expansion of cardio-respiratory wearable

Singapore, Feb. 27 -- Singapore-based health tech startupRespireehas received clearance from the Health Sciences Authority (HSA) to extend its RS001 cardio-respiratory wearable to paediatric populatio... Read More


Sunflower Therapeutics announces commercial launch of Daisy Petal Perfusion Bioreactor System in Asia

Singapore, Feb. 26 -- US-basedSunflower Therapeuticshas announced its first distribution agreement withPharmNXT Biotech, an Indian bioprocessing company. Through this agreement, Sunflower will commerc... Read More


Olympus plans launch of iTind device in Korea for expanded availability across APAC markets

Singapore, Feb. 26 -- Olympus Corporation of Asia Pacific (APAC) has announced a milestone for its iTind device with expanded availability across major markets in the APAC region, a move in line with ... Read More


India explores development of joint research, clinical trials, and technology-driven solutions with Queensland

Singapore, Feb. 26 -- Trade and Investment Queensland (TIQ), the Queensland Government's dedicated business agency presented a 20 member high profile delegation, in the presence ofGovernor of Queensla... Read More


Esco Lifesciences Group partners with Allwin Medical Devices to expand IVF portfolio

Singapore, Feb. 26 -- US-based Allwin Medical Devices Inc., a leading manufacturer of a wide range of medical devices addressing women's health, urology, gastroenterology and interventional radiology ... Read More


HBM Alpha Therapeutics inks deal worth $395 M to advance novel endocrine therapies

Singapore, Feb. 26 -- US-based startup HBM Alpha Therapeutics (HBMAT), Inc., an innovative biotechnology company incubated by China-based Harbour BioMed (HKEX: 02142), has announced a strategic collab... Read More


Australian government invests $6.7 M to expand rare cancer portal

Singapore, Feb. 26 -- The Albanese Labor Government is investing $6.7 million to ensure that people with rare cancers can access expert advice and the best possible care, regardless of where they live... Read More


BIOPLUS-INTERPHEX KOREA 2025: The Ultimate Biopharma Innovation Hub Returns to Seoul

Singapore, Feb. 26 -- A Leading Center for Biopharma Excellence BIX has established itself as a must-attend event for professionals across the entire biopharmaceutical value chain. The exhibition and... Read More


Israel-based CollPlant expands distribution for VergenixSTR in Europe and Asia

Singapore, Feb. 25 -- Israel-based CollPlant Biotechnologies, a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen fo... Read More